Alzheimer's Disease Trial, Recruiting NCT05139290 Sponsor: Emory University Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Recruiting

NCT05139290
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

If you are a person living with memory loss or dementia (PLWD):

  • You self-identify as African American
  • You are 50 years of age or older
  • You live in the community (not in a nursing home or care facility)
  • You are showing signs of mild to moderate dementia, based on a family caregiver's report and meeting standard medical criteria for probable Alzheimer's disease (confirm with trial site)
  • You are able to read, speak, and understand English
  • You are willing to take part in the study

If you are a caregiver:

  • You self-identify as African American
  • You are 18 years of age or older
  • You are a daughter or daughter-in-law of the person with dementia (including non-biological family relationships)
  • You help the person with dementia with everyday tasks and/or decisions about their care
  • You are involved in making formal care decisions for the person with dementia
  • You are able to read, speak, and understand English
  • You have no significant memory or thinking problems yourself
  • You have access to an internet connection
  • You have access to a phone or computer that can receive emails

If you are a "key informant" (an experienced caregiver):

  • You meet all the caregiver criteria listed above
  • You have personal experience navigating at least 2 of the following for a parent with dementia: getting a formal diagnosis, finding or changing a healthcare provider, managing medications, receiving treatment or having a procedure, or discussing hospice, palliative care, or end-of-life care

If you are a past caregiver:

  • You meet all the caregiver criteria, but you are no longer actively providing care because your parent has passed away or has moved into a long-term care facility
  • If your parent has passed away, this must have happened at least 12 months before joining the study

If you are a caregiver for someone with severe dementia:

  • You meet all the caregiver criteria, and you are currently caring for a parent whose dementia is at a severe stage, based on a standard caregiver report (confirm with trial site)

Who may not be able to join:

For persons living with dementia (PLWD):

  • You have another significant brain or neurological condition, such as Parkinson's disease
  • You have a major mental health condition, such as schizophrenia

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Kalisha Bonds Johnson, PhD RN PMHNP, Emory University

Phone: 404-727-5937

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
15 July 2022
Est. completion
1 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Participant retention; Usability of Intervention; Percentage of recruitment goal achieved; Change in Quality of Life-Alzheimer's Disease (QoL-AD) Scale Score; Change in Decision Self-Efficacy Scale Score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov